On the other hand, conflicting reports have demonstrated that kynurenine does not alter AhR activity or invasion of glioblastoma cells, and that the AhR antagonist, CH-223191, inhibits glioblastoma invasion in an AhR-independent manner in both AhR-expressing and AhR-silent cell lines (69). The gene discussed is AHR; the disease is glioblastoma.